COL12A1 and ovarian carcinoma: Increased COL12A1 expression has also been reported in ovarian cancer A2780 cisplatin-resistant (23.9-fold change increased) and A2780 doxorubicin-resistant cell lines (16.4-fold change increased) compared to parental A2780 cells [20].